Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Intangibles (2016 - 2025)

Lisata Therapeutics filings provide 11 years of Intangibles readings, the most recent being $139000.0 for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles fell 33.81% year-over-year to $139000.0, compared with a TTM value of $139000.0 through Sep 2025, down 33.81%, and an annual FY2024 reading of $192000.0, down 27.0% over the prior year.
  • Intangibles hit $139000.0 in Q3 2025 for Lisata Therapeutics, down from $157000.0 in the prior quarter.
  • The five-year high for Intangibles was $317000.0 in Q1 2023, with the low at $139000.0 in Q3 2025.
  • Median Intangibles over the past 3 years was $228000.0 (2024), compared with a mean of $227727.3.
  • The sharpest move saw Intangibles dropped 22.71% in 2024, then plummeted 33.81% in 2025.
  • Year by year, Intangibles stood at $263000.0 in 2023, then fell by 27.0% to $192000.0 in 2024, then decreased by 27.6% to $139000.0 in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $139000.0, $157000.0, and $174000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.